Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma

被引:3
作者
Deberti, M. [1 ,2 ]
Goupille, C. [1 ,2 ,3 ]
Arbion, F. [4 ]
Vilde, A. [5 ]
Body, G. [1 ,2 ,3 ]
Ouldamer, L. [1 ,2 ,3 ,6 ]
机构
[1] Ctr Hosp Reg Univ Tours, Hop Bretonneau, Dept Gynaecol, 2 Blvd Tonnelle, F-37044 Tours, France
[2] Francois Rabelais Univ, Tours, France
[3] INSERM, Unit 1069, Tours, France
[4] Ctr Hosp Reg Univ Tours, Hop Bretonneau, Dept Pathol, 2 Blvd Tonnelle, F-37044 Tours, France
[5] Ctr Hosp Reg Univ Tours, Hop Bretonneau, Dept Radiol, 2 Blvd Tonnelle, F-37044 Tours, France
[6] CHU Bretonneau, Dept Gynoncol, 2 Blvd Tonnelle, F-37000 Tours, France
关键词
Breast cancer; Invasive lobular carcinoma; Lymph node involvement; pN Classification (TNM); LNR ratio; Metastasis; Overall survival; Survival without metastasis; CANCER; RATIOS;
D O I
10.1016/j.jogoh.2023.102665
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Axillary lymph node involvement is a well-established prognostic factor for recurrence in breast cancer, specifically the number of nodes affected and the ratio of the number of affected nodes to the number of harvested nodes for non-specific invasive breast cancer (invasive ductal carcinoma). However, there is limited information on the impact of lymph node involvement in the case of invasive lobular carcinoma. Objectives: our study aimed to evaluate the prognostic impact of lymph node involvement on overall survival and distant metastatic-free survival according to the number of nodes affected and the ratio of positive nodes (LNR) for patients managed for invasive lobular carcinoma. Methods: This is a monocentre, comparative, observational study of patients managed for invasive lobular carcinoma at the Gynaecology Department of the University Hospital Center of Tours between January 1, 2007 and December 31, 2018. The LNR cut-off values used were: low risk if LNR <= 0.2; intermediate risk if LNR > 0.2 and <= 0.65, and high risk for LNR >0.659. Results: Our study demonstrated a significant difference in overall survival and distant metastasis free survival (p < 0.0001). The 5-years Overall survival was 94 % for N0 patients, 92.4 % for low-risk patients, 85.6 % for intermediate-risk patients and 58.5 % for high-risk patients. The 5-year distant metastasis-free survival was 98.2 % for N0 patients, 95.9 % for low-risk patients, 80.1 % for intermediate-risk patients, and 60.3 % for high-risk patients. Multivariate analysis identified age, invasive lobular histologic type, presence of clinical inflammation, and intermediate and high risk classes of LNR ratio as independent factors affecting overall survival. For metastatic-free survival, the presence of clinical inflammation, the presence of LVSI and the low, intermediate, or high-risk classes of LNR ratio were identified as independent factors. However, age and invasive lobular histologic type did not appear to be independent factors affecting metastatic-free survival. Conclusion: Our study highlights the significant prognostic impact of lymph node involvement in patients with invasive lobular carcinoma. The LNR ratio can be used as a reliable predictor of overall survival and metastatic-free survival in these patients.
引用
收藏
页数:6
相关论文
共 19 条
[1]  
BORST MJ, 1993, SURGERY, V114, P637
[2]  
Brierley JD., 2017, TNM CLASSIFICATION M
[3]   Axillary lymph node status and invasive lobular breast cancer Analysis of the Clinical Tumor Register of the AGO Austria [J].
Danzinger, Sabine ;
Poeckl, Karin ;
Kronawetter, Gerit ;
Pfeifer, Christian ;
Behrendt, Sandra ;
Gscheidlinger, Patricia ;
Harrasser, Lois ;
Muehlboeck, Helmut ;
Dirschlmayer, Walter ;
Schauer, Christian ;
Reitsamer, Roland ;
Uher, Heidemarie ;
Schoenau, Kristina ;
Delmarko, Irmgard ;
Singer, Christian F. .
WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (17-18) :463-471
[4]  
FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO
[5]  
2-3
[6]   Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial [J].
Giuliano, Armando E. ;
Hunt, Kelly K. ;
Ballman, Karla V. ;
Beitsch, Peter D. ;
Whitworth, Pat W. ;
Blumencranz, Peter W. ;
Leitch, A. Marilyn ;
Saha, Sukamal ;
McCall, Linda M. ;
Morrow, Monica .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (06) :569-575
[7]  
Goetz MP, 2018, J Natl Compr Canc Netw, V17, P118
[8]   Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer [J].
Hatoum, Hassan A. ;
Jamali, Faek R. ;
El-Saghir, Nagi S. ;
Musallam, Khaled M. ;
Seoud, Muhieddine ;
Dimassi, Hani ;
Abbas, Jaber ;
Khalife, Mohamad ;
Boulos, Fouad I. ;
Tawil, Ayman N. ;
Geara, Fadi B. ;
Salem, Ziad ;
Shamseddine, Achraf A. ;
Al-Feghali, Karine ;
Shamseddine, Ali I. .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (12) :3388-3395
[9]   Significance of axillary lymph node metastasis in primary breast cancer [J].
Jatoi, I ;
Hilsenbeck, SG ;
Clark, GM ;
Osborne, CK .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2334-2340
[10]   Lobular invasive breast cancer prognostic factors: About 940 patients [J].
Jauffret, C. ;
Houvenaeghel, G. ;
Classe, J. -M. ;
Garbay, J. -R. ;
Giard, S. ;
Charitansky, H. ;
Cohen, M. ;
Belichard, C. ;
Faure, C. ;
Darai, E. ;
Hudry, D. ;
Azuar, P. ;
Villet, R. ;
Gimbergues, P. ;
de Lara, C. Tunon ;
Martino, M. ;
Coutant, C. ;
Dravet, F. ;
Chauvet, M. -P. ;
Ewald, E. Chereau ;
Penault-Llorca, F. ;
Goncalves, A. ;
Lambaudie, E. .
GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2015, 43 (11) :712-717